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Abstract
Microbial colonization on biomaterials
is the main cause of failure of a successful
implantation. In fact, local infections can
eventually evolve in severe sepsis that
might finally end up in a multi-organ failure
and death of the patient. Besides, infection
has become one of the toughest problems in
the medical world, as microorganisms
become more resistant to known drugs.
Scientific research has been focussing on
exploring new strategies to combat this life-
threatening problem. In this review, infor-
mation was collected about currently used
polymeric biomaterials in the medical field
and the main bacterial infections associated
with their implantation. Furthermore, drug-
free strategies to overcome this complica-
tion are explored, and the existing method-
ology required for assessment of the
antibacterial activity is also described.
Introduction
The emergence of antibiotic-resistant
infections is a continuous threat to public
health. Despite the efforts made by the
World Health Organization, antimicrobial
resistance (AMR) is still a real problem that
threatens the successful prevention and
treatment of an ever-increasing range of
infections caused by bacteria, parasites,
viruses and fungi.1,2 The impact of AMR on
patients in medical institutions is a serious
challenging problem that leads to increased
morbidity and mortality rates. In fact, cur-
rently in the European Union, AMR infec-
tions cause approximately 25,000 deaths
per year. Globally, the mortality rate is
700,000 people, but it has been estimated
that deaths attributable to AMR infections
will probably rise from the current estimate
to ten million lives annually by 2050.3
Moreover, AMR induces dramatic
changes in the healthcare system through
augmentation of costs associated with pro-
longed hospital stays, and implementation
of safety, hygiene and environmental pro-
tective habits. In hospital surveillance pro-
grams the most commonly tracked AMR
microbes are bacterial species (e.g.
Staphylococcus aureus, Enterococcus spp.,
Clostridium difficile, Escherichia coli and
Klebsiella pneumoniae).4 Bacterial infec-
tions are particularly problematic because
several bacterial strains can easily and
rapidly mutate their genes obtaining an
increasing resistance to a wide-spectrum of
currently used antibacterial drugs.
Nowadays, medical practice is depen-
dent on a large number of instruments,
devices and implants. Biomaterials used to
produce medical devices (e.g. pacemakers,
biosensors, artificial hearts, blood tubes)
and implants (e.g. sutures, bone plates, joint
replacements, ligaments, vascular grafts,
heart valves, intraocular lenses, dental
implants) are widely applied to improve the
quality of life of patients for the replace-
ment or regeneration of traumatized/degen-
erated tissues/organs, assistance in healing,
or improvement of tissue functions and/or
correction of abnormalities. Unfortunately,
these materials often present an optimal sur-
face for bacterial adhesion leading to the
biofilm formation. Biofilm structures are
characterized by a complex community
interaction that provides microbes with a
high tolerance to antibiotics and immune
cells.5 Therefore, resistant bacterial strains
continue to emerge and cause extreme
infections to humans. Despite the presence
of advanced sterilization procedures, it is
still complicated to eradicate bacteria and
maintain sterility of materials for biomedi-
cal applications, without frequent use of
disinfectants.6 The incidence of implant-
related infections is constantly increasing
mainly due to the growing number of
orthopaedic replacements in the aging pop-
ulation and its longer residency time inside
the patient (continuous risk for infection
during their implanted lifetime).7 A notable
example of the growing request is the num-
ber of total hip replacements in the USA,
that in a period of only 17 years increased
two-fold, and the number of total knee
arthroplasties increased almost five-fold.8
Thus, there is an urgent need to develop
new strategies to solve this challenging sit-
uation.
The use of potent antibacterial materials
that are effective against a broad range of
pathogenic bacteria could help to mitigate
and/or eradicate these infections. In this
context, drug-free polymeric materials with
intrinsic antibacterial properties have
gained interest from both academic and
industrial point of view. Antibacterial poly-
mers that are biocompatible and provided
with suitable physicochemical properties
can be used in bioactive medical devices for
diverse biomedical applications. Moreover,
the use of the intrinsic antibacterial capacity
of drug-free antibacterial polymers is a
great strategy to mitigate the AMR infec-
tions in the society.
In this review, we collected information
about common polymeric biomaterials used
in the medical field and the main bacterial
infections associated with their implantation.
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Furthermore, possible drug-free strategies to
overcome bacterial infections were also pro-
posed, and the methods for biological char-
acterization of biomaterials in respect to dif-
ferent pathogenic strains were described.
Polymeric biomaterials in the
biomedical field
Medical grade polymers are biocompat-
ible materials that can be either biore-
sorbable or biostable, depending on their
ability to degrade or not to degrade once
implanted in vivo. In the following subpara-
graphs, these two classes of medical grade
polymers are described.
Bioresorbable polymers
Bioactive biomaterials are typically
designed to elicit an effective interaction
with tissues, provoking physiological
responses such as cell growth and/or cell
differentiation at the site of implantation.9
Bioactive biomaterials are generally biore-
sorbable as they degrade in vivo through
progressive reduction of their molecular
weight, triggered by the biological environ-
ment (e.g. the presence of water and/or spe-
cific degradative enzymes), and further
bioresorption, as the degradation residues
are eliminated by the metabolic pathways of
the organism.9
Bioresorbable polymers can be synthet-
ic, i.e. industrially synthesised, or of natural
origin, i.e. derived from natural sources.
One of the most common bioresorbable
synthetic polymers is poly(lactic acid)
(PLA), also known as polylactide, which is
synthesised from lactide monomers.10
When in the body, PLA degrades into lactic
acid, a non-toxic chemical product, which
occurs naturally in the body.10 For its degra-
dation into non-toxic products, PLA has
been used in medical implants in the form
of anchors, screws, plates, pins, rods, and as
meshes.11 Depending on the PLA stereo-
chemistry, the polymer may degrade inside
the body within 6 months (amorphous poly-
mer) to 2 years (semi-crystalline polymer).
A gradual degradation rate is desirable to
support structures, as they gradually trans-
fer the load to the local tissues (e.g. bones in
case of bone remodelling) while the treated
area heals.12 PLA is subjected to a bulk
hydrolytic degradation mechanism that
means that the degradation rate is faster
inside the polymer bulk than on its surface;
hence, the implant keeps its shape, up to the
last steps of its life-time before fragmenta-
tion and complete degradation.
Polycaprolactone (PCL) is a semi-crys-
talline polyester with good organic solvent
solubility, a melting temperature of 55-60°C
and glass transition temperature of −54°C.
Due to a low in vivo degradation rate and
high drug permeability PCL can be used in
long-term implant delivery devices.13
Current research is being conducted into the
development of micro- and nano-sized drug
delivery vehicles, but the average degrada-
tion rate (2-3 years) is a significant issue for
pure PCL products to be approved by the
Food and Drug administration (FDA) for
this issue.13 PCL is often blended or copoly-
merized with  bioresorbable polymers like
other polyesters or polyethers to expedite
polymer erosion.13
Polyglycolic acid or polyglycolide
(PGA) which degrades into glycolic acid is
another type of bioresorbable polymer usu-
ally used for bioresorbable sutures.10 The
material can be copolymerised with lactic
acid to form poly(lactic acid-co-glycolic
acid), with e-caprolactone to form poly(gly-
colide-co-caprolactone), and with trimethy-
lene carbonate to form poly(glycolide-co-
trimethylene carbonate).10 PGA is highly
semi-crystalline and relatively more
hydrophilic, and degrades rapidly through a
bulk degradation mechanism by hydrolysis,
generally within 6-8 months, depending on
the molecular weight and the crystallinity
degree.
Polyhydroxylalkanoates (PHAs) are
polyesters synthesized by many gram-posi-
tive and gram-negative bacteria from at
least 75 different strains.14 These polymers
are accumulated within cells to levels as
high as 90% of the cell dry weight under
conditions of nutrient stress and act as a car-
bon and energy reserve.14 As they are gen-
erally biodegradable, PHAs are attractive as
biomaterials for applications in both con-
ventional medical devices and tissue engi-
neering.15 PHAs generally degrade through
a surface erosion mechanism by hydrolysis
due to their hydrophobicity.
Polyurethanes (PUs) are a large class of
polymeric materials that contain a urethane
moiety in their chemical repeating structure.
PUs are composed by three main
monomers: a diisocyanate, a macrodiol
(which is an oligomeric macromonomer)
and a chain extender. These monomers react
to form linear copolymers, showing a two-
phase structure in which hard segment-
enriched domains (derived from the reac-
tion of the diisocyanate and the chain exten-
der) are dispersed in a matrix of soft seg-
ments (macrodiol moieties). The particular
molecular architecture and the intrinsic
properties of each constituent influence PU
degradation rate.16 PUs are known to under-
go hydrolytic degradation due to the sus-
ceptibility to hydrolysis of urethane and
urea linkages present in the main chain.17,18
Particularly, the polyol (macrodiol) chemi-
cal structure which forms the soft segments
is the main responsible for the hydrolytic
degradation of biodegradable PUs: PCL
diols, poly (ethylene glycol) (PEG) diols,
poly (propylene glycol) diols, or polyols
based on hydroxy acids such as glycolic
acid, lactic acid and their copolymers are
generally employed for biodegradable PU
synthesis. The PU degradation kinetics is
affected by hydrophilic (e.g. PEG) or
hydrophobic (e.g. PCL) nature of polyols:
the higher is the content of hydrophobic
polyols, the lower is the water uptake and
the degradation rate.19 Moreover, when
using polyether polyols in PU synthesis,
PUs are subjected to oxidative degradation
of their ether linkages because of several
biological events (i.e. monocyte recruit-
ment, differentiation into macrophages and
release of biologically active molecules).20
Additionally, by incorporating chain exten-
ders based on amino acids or enzymatically
cleavable peptides into the PU structure,
PUs with degradable hard segments have
been developed to enhance enzyme mediat-
ed degradation.21,13
Natural polymers, such as collagens,
cellulose, chitosan, etc. may also be used
for antibacterial applications. Chitosan, a
hydrophilic biopolymer industrially
obtained by N-deacetylation of chitin,
found in shrimp and other crustaceans, can
be applied as an antimicrobial material.22
Cellulose can be extracted from plants and
it is composed of beta-linked D-glucose
units.23 Collagens are the main structural
proteins in animal connective tissue.23,24
Antibacterial properties can be conferred to
polymers, for example, by functionalizing
polymers with antibacterial agents such as
silver nanoparticles preparing polymer
composites, or by conjugating antibacterial
groups to synthetic polymers.22,25-27 Table
128 illustrates advantages and disadvantages
of natural polymers.
Table 1. The advantages and disadvantages of natural polymers.28
Advantages                                                      Disadvantages
No severe systemic toxicity                                            Possibility to transmit animal pathologies
Bioactivity                                                                            High natural variability
Rapid degradation by enzymes                                       Material structural complexity 
Crosslinking can slow down degradation rate            
                             Review
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Current food and drug administra-
tion-approved and commercially
used bioresorbable polymers
Medical devices made from biore-
sorbable polymers have already reached a
good deal of commercial success.29
Capronor® is a commercial contraceptive
PCL product that is able to deliver lev-
onorgestrel in vivo for over a year and has
been on the market for over 25 years.30 For
example, products like Ethicon’s
Securestrap®, a device used for mesh fixa-
tion in endoscopic procedures, have already
provided bioresorbable technology to
patients.29 Another company, Meredian
Inc., is positioned as the world largest man-
ufacturer of PHAs and the only one world-
wide whose medium-chain-length PHA is
approved for food substance contact by the
United States FDA.31
Biostable polymers
Biostable polymers including nylon,
polyethylene terephthalate, poly(1,4-buty-
lene terephthalate), and some types of
polyurethanes are used extensively in dif-
ferent biomedical applications, such as non-
absorbable surgical sutures, tissue engineer-
ing scaffolds, films, foams, short-term med-
ical devices (catheters, endotracheal tubes,
cannulas), long-term implantable devices
(vascular prostheses, intra-aortic balloons,
cardiac pacemakers), and drug infusion
pumps, and are considered safe.32
The biostability of PUs in biological
environment is mainly affected by the
chemical composition of soft and hard seg-
ments as well as the associated morphology.
PUs with a high level of soft segments (soft-
er grades) tend to degrade significantly
more than the harder grades.33 Polyester
PUs are subjected to hydrolytic degradation
and are not used in long-term implanted
devices. Polyether PUs are hydrolytically
stable but they are subjected to oxidative
degradation in several forms including
environmental stress cracking and metal ion
oxidation. To increase the PU stability in
biological environment, the main approach
has been replacement of the polyether or
polyester soft segments with macrodiols
with chemical functional groups less sus-
ceptible to oxidative and hydrolytic degra-
dation. Hence, macrodiols based on poly-
carbonate, hydrocarbon and siloxane func-
tionalities have been used in the soft seg-
ment of biostable PUs.18,34-36
Bacterial infections on implanted
biomaterials
Bacterial biofilms produced on the sur-
face of medical materials (both temporary
and permanent implants) are a considerable
issue that may turn a successful treatment
into a significant risk for patients’ health,
causing infectious diseases that in a long-
term may also lead to death. As represented
in Figure 1, from a real case of a patient that
unfortunately developed a late periprosthet-
ic joint infection, most free-living bacteria
(planktonic) species have the capacity to
grow in groups attached to a surface in a
remarkably complex community of
microorganisms encapsulated within a
growing biopolymeric matrix, known as
biofilm.37,38 This adaptation allows them to
tolerate external unfavorable
environments.5,39 In these structures, bacte-
rial organisms communicate, coordinate
their activity and cooperate with each other.
Biofilm formation is initiated and main-
tained when bacteria attach more firmly to a
surface secreting self-expressed biomacro-
molecules and creating a matrix of hydrated
extracellular polymeric substances (EPS)
that forms their own immediate environ-
ment (Figure 1E).37 During the biofilm
development, a high variety of genes are
up-regulated or down-regulated, hence bac-
teria in a biofilm (sessile phenotype)
express different genes when compared to
their planktonic phenotype. One gene that is
clearly up-regulated is the EPS gene that
induces the production of polymeric sub-
stances to form a matrix that protects the
bacterial cells and enhances gathering of
nutrients.40 The confining scaffold formed
by EPS is composed by polysaccharides,
lipids, proteins, extracellular enzymes (e-
enzymes) and extracellular DNA that is
continuously secreted by plasmids (small
pieces of DNA carrying specific genes) and
cells, or released by lysed cells. The EPS
matrix provides mechanical stability to
biofilms, mediates their adhesion to sur-
faces and forms a cohesive three-dimen-
sional polymer network that interconnects
and transiently immobilizes biofilms to
cells.37 As a consequence, bacterial cells
can exchange plasmids and free DNA very
easily and this capacity prepares bacteria
with genetic machinery to persist through
external stresses (e.g. immunity response,
antibiotics, etc.). Another important charac-
teristic within biofilms is the chemical com-
munication performed by bacteria in a pro-
cess known as quorum sensing.41 In this
way, these microorganisms coordinate their
metabolism by sending chemical signals to
other cells nearby and this process increases
the efficiency and resilience of the commu-
nity. The majority of all chronic infections
are due to the bacterial biofilms that colo-
nize either biological surfaces (i.e.
bradytrophic tissue, necrotic tissue) in the
Figure 1. Late periprosthetic joint infection of a male patient with increasing problems
one year after a primary total hip arthroplasty. A) X-ray image showing the left hip region
with the implanted total hip endoprosthesis composed of acetabular cup fixed into the
socket of the hip bone by two pins and three screws, femoral head made of ceramic and
an intramedullary uncemented press-fit stem. The surface of the femoral stem is based on
hydroxyapatite-coated titanium dioxide; B) Enlarged secation of the X-ray image showing
the interface between cortical bone and femoral stem surface. Black arrows are indicating
a radiolucent line at the interface of the femoral component as a sign of osteolysis, a typ-
ical radiological sign of loosening of the femoral stem; C) Three-phase bone scintigraphy
demonstrates the pathological uptake around the total hip replacement in the additional
blood pool image as positive sign of infection and septic loosening; D) Scheme of the
femoral stem – bone interface with the bone resorption zones () showing the typical
arrangement of osteocytes in cortical bone and activated osteoclasts responsible for the
bone resorption. Microbiological analysis of Staphylococcus epidermidis confirmed the
osteoclast activation and thus the PJI; E) Scheme demonstrating the initial step and fol-
lowing sequences of biofilm formation, its maturation and the circulus vitiosus of biofilm-
associated implant infections.
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body or the implant surfaces.42-44 The most
commonly affected medical devices by
biofilm formation include prosthetic heart
valves, orthopaedic devices, tissue fillers,
cardiac pacemakers, intravenous catheters,
etc.42-45 Almost 60 to 70% of nosocomial
infections are due to biofilm formation on
implants.46 Most reported cases are caused
by Staphylococci spp., particularly S.
aureus and Staphylococcus epidermidis fol-
lowed by infection with Pseudomonas
aeruginosa.42-45 Biofilm of S. aureus
species have been found in middle ear,
bones, sutures, central venous catheters,
prosthetic heart valves and joint protheses,
and it leads to implications such as otitis
media, bone infections (i.e. osteitis,
osteomyelitis) and nosocomial infections.
Then, other opportunistic bacteria also get
the chance to infect the host compromised
with medical intervention.5
The bacteria in biofilms show enhanced
resistance to antibiotics and evade the host
immune response that leads to the chronici-
ty and recurrence of infection. In biofilm
bacteria undergo a set of genetic alterations
that indeed promote biofilm formation. For
example, S. aureus secretes thermonuclease
that acts as a regulator for biofilm forma-
tion.47 The altered genetic program includes
the production of extracellular matrix,
which gives the structural stability as well
as protection to the embedded bacteria
against antibiotic agents by accumulating
the antibiotic degrading enzymes. Other
mechanisms involve the production of the
efflux pumps to excrete out the toxic com-
pounds synergistically with other mecha-
nisms like the decrease in outer membrane
permeability. For example, a novel efflux
pump in P. aeruginosa in biofilms was
found to be involved in strong resistance to
aminoglycosides and fluoroquinolones.48
This change in metabolic processes is prop-
agated among the whole bacterial commu-
nity by quorum sensing and by developing
linkages with the surfaces.5 As mentioned
previously, this ability of bacteria to resist
to the effect of antibiotics is intrinsic to the
nature of biofilms. Significant efforts have
been made to understand these enduring
mechanisms, because this information is
important to develop drug-free antibacterial
polymers and implants as novel therapeutic
strategies.
Antibacterial functionalities for
polymeric biomaterials
Antimicrobial polymers represent a
promising class of biomaterials showing not
only antibacterial high efficacy but also less
susceptibility to the development of bacteri-
al resistance. According to the type of poly-
meric system, antibacterial polymers can be
classified into: i) polymers with intrinsic
antimicrobial activity or ii) polymers in
which the antimicrobial function is
achieved by the conjugation of the antibac-
terial functionalities onto the polymer back-
bone or by loading an antibacterial filler
into the polymer matrix. There are some
general principles to introduce antibacterial
properties to the polymeric surfaces (Figure
2).49
Cationic polymers, silver ions, quater-
nary ammonium moieties, silica- and car-
bon-based materials, reactive oxygen-
species generating conjugated polymers,
antimicrobial peptides, etc. have been wide-
ly studied as new antimicrobial agents.50
Among them, cationic natural and synthetic
polymers have gained an increasing interest
as they offer several advantages: i) they
minimize the environmental concerns and
ii) they show flexible properties, robustness
and proven efficacy against resistance
development.50,51
Natural cationic polymers generally
possess a high biocompatibility while syn-
thetic polymers allow a precise control of
their properties and changes, among which
the molecular weight distribution, polarity
and the degradability of the chains. The
main mechanism involving both natural and
synthetic cationic polymers to kill bacteria
is based on: i) the adsorption of the antibac-
terial agent on the walls of the bacteria; ii)
the diffusion through the cell wall and iii)
the disruption of the cytoplasmic mem-
brane.52 Common investigated cationic
polymers are chitosan (CS),
poly(ethyleneimine) (PEI), poly-L-lysine
(PLL), poly[2-(N,N-dimethylamino)ethyl-
methacrylate] (PDMAEMA) and polyami-
doamine (PAA).50,52
CS is obtained by deacetylation of
chitin that is the second most abundant nat-
ural biopolymer commonly found in the
exoskeleton of shrimps and crabs or even
on the cell walls of fungi. It is a linear, semi-
crystalline polysaccharide composed of ran-
domly or block distributed N-acetylglu-
cosamine and D-glucosamine units through
the CS chain.53 CS has found many applica-
tions in biomedical formulations over
recent decades, being a non-toxic,
biodegradable and biocompatible polymer
with antioxidant and antibacterial proper-
ties.54,55 The degrees of deacetylation and
molecular weight affect the cationic proper-
ties of CS by varying the positive charge
density and as a consequence its antibacte-
rial activity.55 CS is soluble in diluted acidic
aqueous solutions (pH<6) by protonation of
the –NH2 function on the C2 position of the
D-glucosamine repeating unit, allowing the
cationic nature to the polymer.56 CS can be
processed into various forms57-65 and can
form ionic complexes with a wide variety of
natural or synthetic anionic species, such as
metal ions,66-68 proteins,69,70 DNA,71,72 and
some negatively charged synthetic poly-
mers.73,74 However, the mechanism by
which CS exerts its antimicrobial activity is
still unknown. Three different approaches
have been proposed: i) the –NH3+ groups of
CS interact with the negatively charged
components (e.g. lipopolysaccharides and
proteins) of bacterial cell wall changing the
permeability barrier properties and inducing
the disruption of intracellular compo-
nents;75,76 ii) CS interaction with the DNA
of the cell and subsequent inhibition of
DNA transcription and protein synthesis;77
iii) the microorganism growth inhibition
associated to the chelating capacity of CS to
trace metals (e.g., iron, copper or zinc).77
PLL is a cationic homopolymer of the
amino acid L-lysine and is composed of a
large number of primary amines which
enable efficient complexation of polyanions
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Table 2. Common natural and synthetic cationic polymers used in therapeutic applications.
Cationic polymer                               Structure                                                              Nature                                                          References
Chitosan                                                                                                                                                                Polysaccharide: N-acetyl glucosamine                    54, 55, 57-72, 
                                                                                                                                                                                  and D-glucosamine                                                       74, 75, 102
Poly(ethyleneimine)                                                                                                                                          Linear poly(ethyleneimine)                                      83-87
                                                                                                                                                                                  contains secondary amines.
                                                                                                                                                                                  Branched PEIs contain primary, 
                                                                                                                                                                                  secondary and tertiary amines.                                 
Poly-L-lysine                                                                                                                                                         Homopolymer of the amino acid L-lysine               78-81
Poly[2-                                                                                                                                                                     Synthetic cationic polymers containing                  91, 93, 95
(N,N-dimethylamino)                                                                                                                                          tertiary amino groups
ethylmethacrylate]                                                                                                                                               
                                                                                                                                                                                                                                                                            
Polyamidoamine                                                                                                                                                  Polymers with amine and amide functionalities.  97-100
through electrostatic interaction when pro-
tonated (under pI, which is around 9). The
electrostatic interaction disturbs the cell
membrane, leading to the formation of
pores and the entrance of PLL into the cell
cytoplasm, with reactive oxygen species
generation and, finally, cell death. However,
PLL molecular weight directly affects the
antimicrobial activity and cytotoxicity.78
Among PLL, epsilon-poly-l-lysine, with
25-35 lysine residues, shows a wide range
of antimicrobial activity against different
pathogens including both Gram-positive
and Gram-negative bacteria,79,80 heat stabil-
ity and lack of toxicity and is generally
regarded as safe as food preservative.81
PEI is a polycationic aliphatic polymer
characterized by the presence of primary,
secondary, and tertiary amino groups. Since
PEI does not contain quaternary amines,
cationic charges are generated by protona-
tion of the amine groups in the biological
environment, showing a correlation
between environmental pH and cationic
charge density.82 Cationic linear or
branched PEIs have been used as drug car-
riers in biomedical applications because of
their highly positively charged nature and
their condensing ability for anionic struc-
tures, such as DNA and siRNA.83,84
However, it has been shown that PEI based
materials induce cytotoxicity.85-87 PEI
antibacterial activity has been primarily
investigated for alkylated permanently
quaternized PEIs used as film coatings or as
nanoparticles integrated in resins, showing
antibacterial effects against both Gram-pos-
itive and Gram-negative bacteria.88-90
pDMAEMA is a mucoadhesive poly-
mer, that is cationic when dissolved into an
acidic media or quaternized by using an
alkylating agent.91 pDMAEMA has been
shown to exhibit antibacterial activity
through the destabilization of the bacterial
membranes by exchange with divalent
cations causing cell death.92,93 In addition,
grafting pDMAEMA to various flat sub-
strates (e.g. glass, polystyrene, silicone) has
been shown to have an antibacterial effect
which is directly correlated to the graft den-
sity of pDMAEMA.91,94,95
PAAs are a new class of hyperbranched,
monodisperse, three-dimensional polymers
that are water-soluble, non-immunogenic
and biocompatible compounds, and their
cytotoxicity is surface charge and concen-
tration dependent.96 Due to their unique
properties, PAAs have been studied as
antibacterial and antifungal drug carriers,
with capacity to improve the drug solubility,
therapeutic efficiency, and permeation.97-99
Moreover, the amino-terminated PAAs den-
drimers have been shown to intrinsically
possess a high antibacterial efficacy, associ-
ated to the electrostatic interaction between
the cationic dendrimer and the anionic bac-
terial cell surface with resultant disruption
of the lipid bilayer and subsequently cell
lysis.100
Studies have shown that cationic poly-
mers suffer from their high charge-associat-
ed toxicity.85-87,101,102 To overcome this
drawback, amphiphilicity is generally intro-
duced in the cationic polymers mimicking
host defense peptides, which also contain
hydrophobic and cationic domains. Table 2
reports a summary of natural and synthetic
cationic polymers used in therapeutic appli-
cations.
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Polymer composites with anti-
bacterial properties
An antibacterial polymer is a material
consisting of a polymer matrix and an
antibacterial functionality that inhibits the
growth of targeted microorganisms.103 As
described above, the antibacterial properties
of a polymer can be intrinsic or achieved by
direct incorporation of the antibacterial
functionality in the polymer backbone or
through the immobilization of the antimi-
crobial agents on a carrier and its subse-
quent incorporation into a polymer matrix,
obtaining an antibacterial polymer compos-
ite.103 Polymer composites are generally
prepared by melt-compounding the thermo-
plastic polymer and the filler in a desired
relative proportion.
Table 3 reports several recent studies on
antibacterial polymer composites and high-
lights the key findings.
In recent studies, several polymer com-
posites have been obtained to enable them to
slowly release metal ions, such as silver,
zinc, magnesium, copper ions, or a combina-
tion of them, to act as antibacterial agents
being extremely toxic to most bacteria and
yeast at exceptionally low concentrations.104-
108 Unlike other antimicrobial agents (i.e.
peptides), metals or inorganic compounds
(i.e. AgO, ZnO) are stable under conditions
currently found in the industry allowing their
use as additives.107 These metal-based addi-
tives are used as: particles, ions
absorbed/exchanged by different carriers,
salts, hybrid structures etc.107
In other cases, composites have been
obtained with the main aim to improve the
mechanical properties of the polymer
matrix consisting of an antimicrobial poly-
mer, as in the case of composites based on
biocidal poly(vinyl alcohol) (PVA) (i.e.
PVA containing methylated melamine graft-
ed polyvinyl benzylchlori as biocidal addi-
tive) with graphene nanosheets.108,109
Zeolites (loaded with metal ions), multi-
walled carbon nanotubes and nanocrys-
talline cellulose may also act as fillers and
modify the mechanical properties of the
antibacterial polymer.108,110,111
The main requirements of the antibacte-
rial polymer composites collected in Table 3
are uniform dispersion of the antibacterial
agent in the polymer matrix, with the pre-
vention of aggregate formation, and the
controlled release of the antibacterial agent.
A study by Shi et al. addressed the issue of
aggregate formation by immobilizing silver
nanoparticles in cellulose nanocrystals
(CNC).112 CNC is one example of a capping
agent, a material used to inhibit aggregation
by electrostatic and steric repulsion.112
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Table 3. Collection of recent relevant studies on antibacterial polymer composites.
Author and Year                    Polymer Material                        Antibacterial Agent and Composite      Remarks
Shoja et al. 2015104                           Polycaprolactone                                    Zinc oxide microparticles                                    -  Octadecylamine enhanced the surface 
                                                                                                                                                                                                                         adhesion of the ZnO microparticles.
                                                                                                                                                                                                                     -   The Polycaprolactone/Zinc oxide 
                                                                                                                                                                                                                         composite films containing surface-
                                                                                                                                                                                                                         modified microparticles showed superior
                                                                                                                                                                                                                         antibacterial properties against Bacillus
                                                                                                                                                                                                                         subtilis compared to films with unmod
                                                                                                                                                                                                                         fied microparticles
Urbankova et al. 2015103                  Low-density Polyethylene                     Essential oils                                                          -   Uniform dispersion of molecular sieves
                                                                                                                                 (Linalool, Allylanisole, trans-Anethole)                and talc in the low-density Polyethylene 
                                                                                                                                 immobilized on Molecular Sieves                          matrix; poor dispersion of the wood flour 
                                                                                                                                 or Wood Flour, or Talc                                               possibly due to its hydrophilic nature in 
                                                                                                                                                                                                                         nonpolar low-density Polyethylene
                                                                                                                                                                                                                     -   Composites showed enhanced Young’s 
                                                                                                                                                                                                                         modulus 
                                                                                                                                                                                                                     -   Pure low-density Polyethylene and 
                                                                                                                                                                                                                         essential oil-free composites showed no
                                                                                                                                                                                                                         antibacterial activity compared to various
                                                                                                                                                                                                                         essential oil-immobilized composites,
                                                                                                                                                                                                                         showing antibacterial activity on either
                                                                                                                                                                                                                         Gram-positive or Gram-negative bacteria
                                                                                                                                                                                                                         depending on the essential oil and com
                                                                                                                                                                                                                         posite composition
Altan et al. 2014105                            High-density Polyethylene                   Titanium dioxide or Zinc oxide                           -   Silane coating was applied on th
                                                                                                                                                                                                                         Titanium and Polypropylene
                                                                                                                                                                                                                         dioxide or Zinc oxide fillers before melt
                                                                                                                                                                                                                         mixing with polymers to distribute 
                                                                                                                                                                                                                         particles homogeneously in the matrix
                                                                                                                                                                                                                     -   Titanium dioxide showed slightly better 
                                                                                                                                                                                                                         antibacterial efficiency
Kiriyama et al. 2013106                     Self-cured acrylic resin                         Coating based on silver -containing organic   -   Polymer particles with the coating were
                                                                                                                                 composite (70.0 wt% zirconium phosphate        prepared using a polymer processing
                                                                                                                                 ceramics containing silver ions, 29.7 wt%            technique known as surface uniformity
                                                                                                                                 trimethylolpropane trimethacrylate,                     revolutionary fixation technology
                                                                                                                                 0.3 wt% Azo-bis-isobutyronitrile)                       -   Antibacterial activity increased 
                                                                                                                                                                                                                         as a function of silver ions content
                                                                                                                                                                                                                     -   Composites showed antibacterial effect
                                                                                                                                                                                                                         and inhibited biofilm formation against
                                                                                                                                                                                                                         four representative types of bacteria
                                                                                                                                                                                                                         contributing to biofilm on acrylic resin
                                                                                                                                                                                                                         and tooth surfaces
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In vitro tests assessing antibacter-
ial activity of biomaterials
To evaluate the antibacterial potential of
new biomaterials, the first approach is to
perform in vitro testing against the
pathogenic bacterial strains related to the
specific application of the developed mate-
rial. Different in vitro tests have been
reported, but in general they should follow
the international standard operating proto-
cols from International Organization of
Standardization (ISO for biological charac-
terization), European Committee on
Antimicrobial Susceptibility Testing
(EUCAST), Clinical and Laboratory
Standards Institute (CLSI), Japanese
Standards Association (JIS), and American
Society for Testing & Materials (ASTM).
As advised, these guidelines provide a uni-
form procedure for practical testing in most
clinical microbiology laboratories.
The selection of antimicrobial testing
methods depends on the mode of action of
antibacterial agents and how it is affected
by their addition to the polymers. It also
depends on whether the antibacterial agents
are physically incorporated and released, or
chemically immobilized. There are different
mechanisms of antibacterial activity: for
example, bacteria are killed either from
eluting antibacterial agent or by direct con-
tact with the surface of the material through
a biocidal effect or by inhibiting the adhe-
sion to a surface.
The main in vitro tests that can be
applied to assess the antibacterial ability of
a polymeric material are as following.
Zone of inhibition
This assay is used in many clinical
microbiology laboratories for a first assess-
ment of the antimicrobial capacity of a
drug/material. It involves the direct contact
of antimicrobial biomaterials with bacterial
culture, eluting the agents into media and
inhibiting the bacterial growth in that zone.
The size of the zone is important to define
the clinical concentration required to inhibit
bacteria. This test depends on the concen-
tration of the antibacterial agent and its abil-
ity to diffuse.113,114 For example, in the agar
disk-diffusion method and the agar well dif-
fusion method, after the established incuba-
tion endpoint, the diameters of inhibition
growth zones are measured (CLSI stan-
dards). An approximate Minimum
Inhibitory Concentration can be calculated
for some microorganisms by comparing the
inhibition zones with stored algorithms
(EUCAST guidelines).
Immersion inoculation
In this method the sample is immersed
in the bacterial inoculum, and then colony
forming units (CFUs) are counted from the
solution as described by ASTM for testing
of immobilized antimicrobial agents.115 A
similar procedure is the broth dilution
method that is one of the most basic antimi-
crobial tests. The procedure involves the
preparation of serial dilutions of the antimi-
crobial agent in a liquid growth medium.
With the aim to evaluate the percentage of
viable microorganisms, several colorimetric
methods based on the use of dye reagents
can be used, such as 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazoliumbromide, 2,3-
bis{2-methoxy-4-nitro-5-[(sulfenylamino)
carbonyl]-2H-tetrazolium-hydroxide} and
Alamar blue dye (resazurin).116
Direct inoculation
This method as described by JIS Z-2801
uses the bacterial inoculum in the form of
droplet, placed onto the active surface of
antimicrobial biomaterials. After the
required inoculation time the bacterial cells
are released and counted as CFU.117
Surface growth methods
It involves the aerosol inoculation of
bacteria in the form of thin film over the
activated surface that is then tested for the
bacterial growth on agar. This test method is
suitable for testing antimicrobial efficiency
of surfaces.
Methods for viable but not cultur-
able bacteria
Above mentioned methods use the
approach where the bacteria can grow in the
form of colonies that can be detected and
quantified. However, bacterial strains can
enter into viable but not culturable state and
cannot be detected by the previous
assays118,119 but can be detected by other
method (Figure 3). One of the methods is to
measure the adenosine triphosphate (ATP, a
chemical signal from living cells only) by
using the ATP bioluminescence assay. Thus,
there is a linear relationship between the
living microbial cell population and lumi-
nescence signal. Other commonly used
method is the Live/Dead staining that eval-
uates the membrane integrity.120,121 A
research group has developed a technique
using this kit to determine whether the
antimicrobial agent directly kills the cells at
the surface or at distance.122 This assay can
be combined with flow cytometry.
In the last years, research on polymers
with antimicrobial capacity has grown
exponentially mainly due to the increase of
biomaterial-associated infections. Some
examples of antibacterial materials and the
tests performed for their functional analysis
are reported below.
Polymeric surfaces with covalently
bound biocidal quaternary ammonium salts
(QAS) were evaluated through the serial
dilution method. For example, polyurethane
(with QAS) was tested for contact of poly-
mer with bacteria by successive addition of
bacteria (S. aureus, or E. coli) and
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Figure 3. Examples of direct, indirect and viable but non-culturable bacteria assays to
determine bacteria viability.
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Saccharomyces cerevisiae to test whether
the biocidal group retains its efficiency after
repeated interactions with a high number of
bacteria.123,124 In an another study QAS was
covalently bound on the polyethylene back-
bone through a hydrolysable ester linkage,
and a slow release of the antibacterial agent
was found to be effective against S. aureus
and E.coli through serial dilution
method.125
Polymers coupled with antimicrobial
cationic peptides, for example, surface
modified polystyrene, were found to be
microbiocidal against E.coli O157:H7, L.
monocytogenes, S. aureus, P. fluorescens,
K. marxianu in a concentration and time
dependent manner. To test the antimicrobial
effect, samples were incubated with bacteri-
al inoculum and evaluated at multiple time
points by pour plate method.126
In another work, the 2-(2-
methoxyethoxy)ethyl methacrylate-co-
hydroxy-terminated oligo (ethyleneglycol)
methacrylate non-adhesive copolymer
brushes functionalized with natural antibac-
terial peptide (magainin) were tested
against L. ivanovii and B. cereus. To test the
number of adhered bacteria, samples were
stained using LIVE/DEAD bacterial viabil-
ity kit method. On the other hand for the
sessile bacteria L. ivanovii, the adherent
cells were recovered by sonication and test-
ed by plate count method.127
The antibacterial activities of polymeric
composites, for example, PCL/ZnO films
were examined against S. aesuis and B. sub-
tilis by agar disc diffusion method revealing
the enhanced antibacterial activity with the
increasing ZnO amount.104 In another work,
polypropylene and high density polyethy-
lene with nano-sized ZnO and TiO2 fillers
were tested for antibacterial activity using
JIS Z 2801 test that evaluates the antimicro-
bial surface properties of plastics, metal and
ceramics.105 In another study where the
essential oils were used to confer antibacte-
rial properties to low-density polyethylene,
ISO 22196 method was used to evaluate
antibacterial activity against S. aureus and
E. coli.103
An antimicrobial dental resin was
developed based on a self-cured acrylic
resin, composed of a polymer coated with
an antibacterial silver ions-releasing organ-
ic composite. The resin was tested for
antibacterial activity through residual viable
counts of the four bacteria S. mutans, S.
oralis, S. gordonii, A. naeslandii and the
yeast C. albicans, that are involved in initial
biofilm formation on the surface of acrylic
resin and denture stomatitis, respectively.106
A chlorinated coated polyester contain-
ing N-halamine moieties was also prepared
and tested against S. aureus and E. coli
(O157:H7) through the sandwich test
method and biocidal activity analysis was
performed.124
Recent studies have shown the develop-
ment of in vitro biofilm models, especially
chronic wound models for the evaluation of
antibacterial properties. Lubbock Chronic
Wound Biofilm was the first chronic wound
biofilm model used to evaluate the inhibit-
ing efficacy of various biofilm effec-
tors.128,129 Other examples of such models
based on constant depth film fermenter130
and colony-drip flow reactor were used to
evaluate the antibacterial effect of wound
dressings.131
Besides the testing methods described
above, it is of great interest to evaluate the
antibacterial potential of new biomaterials
in more in vivo like situation. Recently,
there has been development of human cells
based three-dimensional in vitro systems
with bacterial infection and biofilm forma-
tion mainly to unravel the poorly under-
stood interactions between pathogenic bac-
teria and human tissue. For example, an in
vitro model of oral and vaginal candidiasis
was developed using reconstituted human
epithelia to demonstrate the interaction
between C. albicans and epithelial tis-
sue.132-135 Charles studied the biofilm for-
mation by wound pathogens S. aureus and
P. aeruginosa using the most advanced tis-
sue engineered wound model based on
Graftskin.136 These advanced systems can
be employed for in vitro screening of both
antibacterial activity as well as cytocompat-
ibility of novel antibacterial biomaterials to
obtain more reliable preclinical data and
better in vivo performances. Moreover, with
the growing emergence of drug resistant
infections worldwide, these systems can
serve as a powerful platform to explore
novel therapeutic approaches against infec-
tions and implant associated infections in a
more in vivo like situation, by demonstrat-
ing the interactions between pathogen and
human tissue.
Conclusions
New bacteria resistance mechanisms
are continuously emerging and spreading
globally, associated with an excessive use
of antibiotics and leading to the formation
of superbugs. Antimicrobial resistance
threatens our ability to treat infections as
well as increases healthcare costs.
As an alternative to antimicrobial drugs,
a new intriguing possibility is the develop-
ment of antimicrobial biomaterials for both
temporary or permanent biomedical appli-
cations. Such biomaterials may be effective
by preventing bacterial adhesion and
biofilm formation or causing bacterial death
(bactericidal effect). Hence, new lines of
research are now emerging for the synthesis
of novel copolymers (e.g. belonging to the
polyurethane family) with intrinsic antibac-
terial properties or able to be conjugated
with functional antibacterial moieties, e.g.
cationic functionalities. Other possibilities
include the incorporation of antibacterial
fillers within a polymer matrix or onto its
surface.
The development of new antimicrobial
biomaterials is possible by a full compre-
hension of the mode of action of the antimi-
crobial functionalities as well as the proper-
ties of the biomaterials. New methods for
antibacterial testing should be developed
for an accurate prediction of the antimicro-
bial behaviour of new antibacterial bioma-
terials. In this context, as described above,
the development of novel human cells
based in vitro microbial infection models
can not only be useful to understand the
basic mechanisms of biofilm formation and
infection persistence but also serve as a
powerful tool for antibacterial testing.
Although not described in this review arti-
cle, new antibacterial promising strategies
avoiding the use of drugs are represented by
surface structuring of biomaterials with
hierarchical micro-/nano-patterns, mimick-
ing the bactericidal surface of cicada wings
and dragon fly or the antibiofouling surface
of shark skin, lotus and taro leaves.51,137,138
In conclusion, advancement in the
knowledge of bacterial biology, as well as
biomaterials science and engineering is
continuously progressing with the aim to
avoid or to treat biomaterial-associated
infections. Novel strategies using drug-free
polymeric materials may mitigate this chal-
lenging worldwide problem. The engineer-
ing of new biomaterial devices with intrin-
sic antimicrobial properties requires collab-
oration among clinicians (e.g. intervention-
al specialists, surgeons, infection disease
specialists) and research groups with com-
plementary expertise in biomedical and
materials engineering, biomaterials science,
biology and biotechnology. Most of the
authors of this review article collaborate in
the HyMedPoly H2020-MSCA-ITN-2014
project, which represents a valuable exam-
ple of such interdisciplinary collaboration,
involving both academic and the industrial
staff.139
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